Growth differentiation factor-9 stimulates progesterone synthesis in granulosa cells via a prostaglandin E(2)/EP2 receptor pathway

od Elvin, Julia A., Yan, Changning, Matzuk, Martin M.
Izdano 2000

Comprehensive genomic profiling (CGP) of ovarian clear cell carcinomas (OCCC) identifies clinically relevant genomic alterations (CRGA) and targeted therapy options

od Elvin, Julia A., Chura, Justin, Gay, Laurie M., Markman, Maurie
Izdano u Gynecol Oncol Rep (2017)

BRCA1 reversion mutation acquired after treatment identified by liquid biopsy

od Mayor, Paul, Gay, Laurie M., Lele, Shashikant, Elvin, Julia A.
Izdano u Gynecol Oncol Rep (2017)

Elevated tumor mutational burden and prolonged clinical response to anti-PD-L1 antibody in platinum-resistant recurrent ovarian cancer

od Morse, Christopher B., Elvin, Julia A., Gay, Laurie M., Liao, John B.
Izdano u Gynecol Oncol Rep (2017)

A recurrent endometrial stromal sarcoma harbors the novel fusion JAZF1-BCORL1

od Allen, Allison J, Ali, Siraj M., Gowen, Kyle, Elvin, Julia A., Pejovic, Tanja
Izdano u Gynecol Oncol Rep (2017)

Unique Genomic Landscape of High-Grade Neuroendocrine Cervical Carcinoma: Implications for Rethinking Current Treatment Paradigms

od Eskander, Ramez N., Elvin, Julia, Gay, Laurie, Ross, Jeffrey S., Miller, Vincent A., Kurzrock, Razelle
Izdano u JCO Precis Oncol (2020)

Tumor Mutational Burden Guides Therapy in a Treatment Refractory POLE‐Mutant Uterine Carcinosarcoma

od Bhangoo, Munveer S., Boasberg, Peter, Mehta, Pareen, Elvin, Julia A., Ali, Siraj M., Wu, Winnie, Klempner, Samuel J.
Izdano u Oncologist (2018)

MPTH-05 NEXT GENERATION SEQUENCING OF GLIOMAS REFINES DIAGNOSIS AND IDENTIFIES TARGETABLE ALTERATIONS IN CLINICAL PRACTICE, BUT RESULTS DEPEND ON THE ASSAY

od Cohen, Adam, Gligorich, Keith, Parnell, Timothy, Elvin, Julia, Ramkissoon, Shakti, Maxwell, Amiee, Palmer, Cheryl, Schiffman, Joshua, Colman, Howard
Izdano u Neuro Oncol (2015)

Genomic Profiling Reveals Medullary Thyroid Cancer Misdiagnosed as Lung Cancer

od Gordon, Eva J., Parker, David, Barth, Kelly, Pena, Jennifer, Elvin, Julia A., DeLeon, Thomas, Karlin, Nina J.
Izdano u Case Rep Oncol (2018)

Prevalence of High-Risk Nonvaccine Human Papillomavirus Types in Advanced Squamous Cell Carcinoma Among Individuals of African vs Non-African Ancestry

od Williams, Erik A., Newberg, Justin, Williams, Kevin Jon, Montesion, Meagan, Alexander, Brian M., Lin, Douglas I., Elvin, Julia A.
Izdano u JAMA Netw Open (2021)

FGFR3–TACC3: A novel gene fusion in cervical cancer

od Carneiro, Benedito A., Elvin, Julia A., Kamath, Suneel D., Ali, Siraj M., Paintal, Ajit S., Restrepo, Alvaro, Berry, Emily, Giles, Francis J., Johnson, Melissa L.
Izdano u Gynecol Oncol Rep (2015)

Genomic characterization of high-risk non-muscle invasive bladder cancer

od Meeks, Joshua J., Carneiro, Benedito A., Pai, Sachin G., Oberlin, Daniel T., Rademaker, Alfred, Fedorchak, Kyle, Balasubramanian, Sohail, Elvin, Julia, Beaubier, Nike, Giles, Francis J.
Izdano u Oncotarget (2016)

PATH-20. COMPREHENSIVE GENOMIC PROFILING COMPARING PRIMARY CNS LYMPHOMA TO SYSTEMIC DIFFUSE LARGE B CELL LYMPHOMA REVEALS BIOMARKERS INDICATING POTENTIAL BENEFIT FROM IMMUNE CHECKP...

od Severson, Eric, Vergilio, Jo-Anne, Gay, Laurie, Daniel, Sugganth, Elvin, Julia, Suh, James, Covert, Mandy, Brown, Charlotte, Miller, Vincent, Stephens, Philip, Ross, Jeffrey, Ramkissoon, Shakti
Izdano u Neuro Oncol (2017)

Exceptional response to pembrolizumab in a metastatic, chemotherapy/radiation-resistant ovarian cancer patient harboring a PD-L1-genetic rearrangement

od Bellone, Stefania, Buza, Natalia, Choi, Jungmin, Zammataro, Luca, Gay, Laurie, Elvin, Julia, Rimm, David L., Liu, Yuting, Ratner, Elena S., Schwartz, Peter E., Santin, Alessandro D.
Izdano u Clin Cancer Res (2018)

BRAF Mutations Occur Infrequently in Ovarian Cancer but Suggest Responsiveness to BRAF and MEK Inhibition

od Campos, Maira P., Cohen, Melissa, Von Euw, Erika, Velculescu, Victor, Kujak, Jennifer L., Conklin, Dylan, Hallberg, Dorothy, Slamon, Dennis J., Elvin, Julia, Konecny, Gottfried E.
Izdano u JCO Precis Oncol (2018)

Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Origin: Retrospective Molecular Classification Considering the CUPISCO Study Design

od Ross, Jeffrey S., Sokol, Ethan S., Moch, Holger, Mileshkin, Linda, Baciarello, Giulia, Losa, Ferran, Beringer, Andreas, Thomas, Marlene, Elvin, Julia A., Ngo, Nhu, Jin, Dexter X., Krämer, Alwin
Izdano u Oncologist (2020)

Comprehensive genomic profiling aids in treatment of a metastatic endometrial cancer

od Dhami, Jatinder, Hirshfield, Kim M., Ganesan, Shridar, Hellmann, Mira, Rojas, Veronica, Amorosa, Judith K., Riedlinger, Gregory M., Zhong, Hua, Ali, Siraj M., Pavlick, Dean, Elvin, Julia A., Rodriguez-Rodriguez, Lorna
Izdano u Cold Spring Harb Mol Case Stud (2018)

CYLD mutation characterizes a subset of HPV-positive head and neck squamous cell carcinomas with distinctive genomics and frequent cylindroma-like histologic features

od Williams, Erik A., Montesion, Meagan, Alexander, Brian M., Ramkissoon, Shakti H., Elvin, Julia A., Ross, Jeffrey S., Williams, Kevin Jon, Glomski, Krzysztof, Bledsoe, Jacob R., Tse, Julie Y., Mochel, Mark C.
Izdano u Mod Pathol (2020)

Comprehensive Genomic Profiling Facilitates Implementation of the National Comprehensive Cancer Network Guidelines for Lung Cancer Biomarker Testing and Identifies Patients Who May...

od Suh, James H., Johnson, Adrienne, Albacker, Lee, Wang, Kai, Chmielecki, Juliann, Frampton, Garrett, Gay, Laurie, Elvin, Julia A., Vergilio, Jo-Anne, Ali, Siraj, Miller, Vincent A., Stephens, Philip J., Ross, Jeffrey S.
Izdano u Oncologist (2016)

Melanomas with activating RAF1 fusions: clinical, histopathologic, and molecular profiles

od Williams, Erik A., Shah, Nikunj, Montesion, Meagan, Sharaf, Radwa, Pavlick, Dean C., Sokol, Ethan S., Alexander, Brian M., Venstrom, Jeff M., Elvin, Julia A., Ross, Jeffrey S., Tse, Julie Y., Mochel, Mark C.
Izdano u Mod Pathol (2020)